Electronic Arts Com (EA) Shareholder Symphony Asset Management Has Increased Stake …

June 28, 2017 – By Dolores Ford

Longwood Capital Partners Llc decreased its stake in Vanda Pharmaceuticals Inc (VNDA) by 33.9% based on its latest 2016Q4 regulatory filing with the SEC. Longwood Capital Partners Llc sold 83,395 shares as the company’s stock declined 5.00% while stock markets rallied. The institutional investor held 162,600 shares of the major pharmaceuticals company at the end of 2016Q4, valued at $ 2.59 million, down from 245,995 at the end of the previous reported quarter. Longwood Capital Partners Llc who had been investing in Vanda Pharmaceuticals Inc for a number of months, seems to be less bullish one the $ 714.98 million market cap company. The stock rose 2.54% or $ 0.4 reaching $ 16.15. About 114,254 shares traded. Vanda Pharmaceuticals Inc. (NASDAQ:VNDA) has risen 51.60% since June 28, 2016 and is uptrending. It has outperformed by 34.90% the S&P500.

Symphony Asset Management Llc increased its stake in Electronic Arts Com (EA) by 22% based on its latest 2016Q4 regulatory filing with the SEC. Symphony Asset Management Llc bought 9,595 shares as the company’s stock rose 23.30% with the market. The institutional investor held 53,208 shares of the prepackaged software company at the end of 2016Q4, valued at $ 4.19 million, up from 43,613 at the end of the previous reported quarter. Symphony Asset Management Llc who had been investing in Electronic Arts Com for a number of months, seems to be bullish on the $ 32.44B market cap company. The stock declined 0.11% or $ 0.12 reaching $ 108.2 on the news. About 1.63M shares traded. Electronic Arts Inc. (NASDAQ:EA) has risen 46.45% since June 28, 2016 and is uptrending. It has outperformed by 29.75% the S&P500.

Among 18 analysts covering Electronic Arts (NASDAQ:EA), 14 have Buy rating, 0 Sell and 4 Hold. Therefore 78% are positive. Electronic Arts had 36 analyst reports since July 28, 2015 according to SRatingsIntel. As per Monday, October 24, the company rating was downgraded by Bank of America. The firm has “Buy” rating by Credit Suisse given on Friday, May 26. Stifel Nicolaus maintained it with “Buy” rating and $ 82 target in Thursday, May 12 report. The firm earned “Buy” rating on Monday, October 17 by Stifel Nicolaus. As per Thursday, November 12, the company rating was initiated by Oppenheimer. The firm has “Neutral” rating by Mizuho given on Wednesday, February 1. The company was maintained on Monday, May 23 by Benchmark. BMO Capital Markets initiated Electronic Arts Inc. (NASDAQ:EA) on Wednesday, April 27 with “Market Perform” rating. On Wednesday, November 2 the stock rating was maintained by Mizuho with “Neutral”. The firm earned “Buy” rating on Wednesday, May 11 by Benchmark.

Symphony Asset Management Llc, which manages about $ 16.99B and $ 956.39M US Long portfolio, decreased its stake in Northrop Grumman Corp Com (NYSE:NOC) by 4,077 shares to 3,904 shares, valued at $ 908,000 in 2016Q4, according to the filing. It also reduced its holding in Babcock & Wilcox Enterpris Ico by 26,602 shares in the quarter, leaving it with 48,915 shares, and cut its stake in Pfizer Inc (NYSE:PFE).

Investors sentiment increased to 0.85 in 2016 Q4. Its up 0.04, from 0.81 in 2016Q3. It improved, as 71 investors sold EA shares while 214 reduced holdings. 65 funds opened positions while 178 raised stakes. 290.67 million shares or 1.29% less from 294.46 million shares in 2016Q3 were reported. 7.00 million are owned by Massachusetts Ser Ma. Moreover, Nippon Life has 0.05% invested in Electronic Arts Inc. (NASDAQ:EA) for 31,658 shares. Moreover, Benjamin F Edwards & has 0.01% invested in Electronic Arts Inc. (NASDAQ:EA). 1.69 million are held by Nordea Inv Ab. Yorktown Mgmt & Research Company Incorporated stated it has 0.07% of its portfolio in Electronic Arts Inc. (NASDAQ:EA). Appleton Prtnrs Ma reported 0.28% stake. Mitsubishi Ufj Securities Ltd holds 90 shares. Vanguard Group Incorporated reported 0.12% in Electronic Arts Inc. (NASDAQ:EA). Baring Asset Management Limited holds 140,145 shares or 0.76% of its portfolio. Wealth Architects Ltd Company reported 0.18% of its portfolio in Electronic Arts Inc. (NASDAQ:EA). Archford Strategies Ltd Llc stated it has 0.05% in Electronic Arts Inc. (NASDAQ:EA). Friess Associate Limited Liability accumulated 206,567 shares. Sumitomo Mitsui Asset Mngmt Co Limited reported 0.22% of its portfolio in Electronic Arts Inc. (NASDAQ:EA). Private Tru Na invested in 3,551 shares or 0.07% of the stock. Bryn Mawr Trust Communications holds 0.01% or 2,900 shares in its portfolio.

Since January 3, 2017, it had 0 buys, and 49 sales for $ 63.85 million activity. Shares for $ 450,000 were sold by LINZNER JOEL. The insider Miele Laura sold $ 34,144. The insider Moss Kenneth A sold $ 416,849. Shares for $ 754,375 were sold by HOAG JAY C on Tuesday, May 23. Shares for $ 950,433 were sold by Jorgensen Blake J. 8,000 shares valued at $ 914,585 were sold by Wilson Andrew on Thursday, June 1.

More important recent Electronic Arts Inc. (NASDAQ:EA) news were published by: Fool.com</a> which released: “Why Shares of Electronic Arts Inc. Popped 20% in May” on June 13, 2017, also Bloomberg.com</a> published article titled: “EA Pays CEO $ 20 Million as FIFA 17 Maker Navigates Shift to Web”, Wsj.com</a> published: “EA Hopes ‘Star Wars Battlefront II’ Microtransactions Can Shift Revenue to …” on June 10, 2017. More interesting news about Electronic Arts Inc. (NASDAQ:EA) was released by: Nasdaq.com</a> and their article: “Electronic Arts Inc (EA) CEO Andrew Wilson Sold $ 11.1 million of Shares” with publication date: June 20, 2017.

Among 7 analysts covering Vanda Pharmaceuticals (NASDAQ:VNDA), 7 have Buy rating, 0 Sell and 0 Hold. Therefore 100% are positive. Vanda Pharmaceuticals had 9 analyst reports since September 2, 2015 according to SRatingsIntel. JMP Securities maintained Vanda Pharmaceuticals Inc. (NASDAQ:VNDA) rating on Friday, August 26. JMP Securities has “Market Outperform” rating and $ 22 target. Jefferies reinitiated Vanda Pharmaceuticals Inc. (NASDAQ:VNDA) on Thursday, October 6 with “Buy” rating. The stock has “Buy” rating by Piper Jaffray on Wednesday, September 2. Aegis Capital initiated the stock with “Buy” rating in Wednesday, November 9 report. The stock has “Market Outperform” rating by JMP Securities on Wednesday, March 9. The firm earned “Buy” rating on Wednesday, October 21 by Brean Capital.

Analysts await Vanda Pharmaceuticals Inc. (NASDAQ:VNDA) to report earnings on July, 26. They expect $ -0.20 earnings per share, down 400.00% or $ 0.16 from last year’s $ -0.04 per share. After $ -0.17 actual earnings per share reported by Vanda Pharmaceuticals Inc. for the previous quarter, Wall Street now forecasts 17.65% negative EPS growth.

More notable recent Vanda Pharmaceuticals Inc. (NASDAQ:VNDA) news were published by: Reuters.com</a> which released: “BRIEF-Armistice Capital Llc reports 5.1 pct passive stake in Vanda …” on June 19, 2017, also Bizjournals.com</a> with their article: “Vanda Pharmaceuticals expands into cystic fibrosis, blood cancer” published on May 04, 2017, Reuters.com</a> published: “Exclusive: Vanda Pharmaceuticals prepares to explore a sale – sources” on September 22, 2016. More interesting news about Vanda Pharmaceuticals Inc. (NASDAQ:VNDA) were released by: Prnewswire.com</a> and their article: “Vanda Pharmaceuticals Reports Preliminary Fourth Quarter and Full Year 2016 …” published on January 09, 2017 as well as Zacks.com</a>‘s news article titled: “Vanda Pharmaceuticals (VNDA) Worth a Look: Stock Jumps 8%” with publication date: June 21, 2017.

Since January 3, 2017, it had 0 insider buys, and 4 selling transactions for $ 952,121 activity. 23,330 shares valued at $ 361,242 were sold by Polymeropoulos Mihael Hristos on Tuesday, January 3. $ 169,090 worth of Vanda Pharmaceuticals Inc. (NASDAQ:VNDA) was sold by Gulino Richard L.. 16,300 shares valued at $ 252,776 were sold by Baroldi Paolo on Tuesday, January 3.

Longwood Capital Partners Llc, which manages about $ 268.92M US Long portfolio, upped its stake in Assembly Biosciences Inc (NASDAQ:ASMB) by 662,388 shares to 976,599 shares, valued at $ 11.87M in 2016Q4, according to the filing. It also increased its holding in Ishares Tr (Put) (IWM) by 30,000 shares in the quarter, for a total of 70,000 shares, and has risen its stake in Edge Therapeutics Inc.

Receive News & Ratings Via Email – Enter your email address below to receive a concise daily summary of the latest news and analysts’ ratings with our FREE daily email newsletter.

Let’s block ads! (Why?)

Google Alert – ea fifa 17 news

Be the first to comment

Leave a Reply

Your email address will not be published.


*